Sima Patent Ve Lisanslama Hizmetleri Ltd.sti. competitive analysis

Explore patent oppositions filed by Sima Patent Ve Lisanslama Hizmetleri Ltd.sti. against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 1, 2026
Patent NumberTitleApplicantOpposition Date
Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor AgonistGLAXO GROUPSep 20, 2018
Use Of A Composition Comprising Formoterol And Beclometasone Dipropionate For The Prevention And/Or Treatment Of An Exacerbation Of AsthmaCHIESI FARMACEUTICIDec 20, 2016

Explore Sima Patent Ve Lisanslama Hizmetleri Ltd.sti.'s recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 1, 2026
Patent NumberPublication DateTitleTotal Oppositions
Nov 4, 2015The Pharmaceutical Composition In Dry Powder Form For Inhalation1
Jun 10, 2015Blister Strip Carrying Dry Powder Composition1

Latest PTAB cases involving Sima Patent Ve Lisanslama Hizmetleri Ltd.sti.

Discover the latest PTAB cases involving Sima Patent Ve Lisanslama Hizmetleri Ltd.sti., highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Sima Patent Ve Lisanslama Hizmetleri Ltd.sti. with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 1, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SIMA PATENT VE LISANSLAMA HIZMETLERI LTD.STI.22 - -
CHIESI FARMACEUTICI1122 - -
CONSTANTIA TEICH131 - -
GLAXO GROUP2326 - -